Intravenous infusion of autologous mesenchymal stem cells derived from bone marrow

4 trials

Sponsors

HISAHARA SHIN, Tomii Ryo, Room Stemirac Information

Conditions

Amyotrophic Lateral Sclerosis (ALS) Amyotrophic Lateral Sclerosis, ALSAmyotrophic lateral sclerosis (ALS)Spinal Cord InjuryTraumatic Spinal Cord Injury

Phase 2

Intravenous infusion of autologous mesenchymal stem cells from bone marrow for ALS patients: double-blind randomized controlled trial

Active, not recruitingJPRN-jRCT2013190010

HISAHARA SHINAmyotrophic Lateral Sclerosis (ALS) Amyotrophic Lateral Sclerosis, ALS

Start: 2020-09-25Target: 40Updated: 2025-07-18

Double-blind, randomized, controlled study of intravenous administration of human mesenchymal stem cells derived from bone marrow in patients with chronic spinal cord injury (AIS C and D).

RecruitingJPRN-jRCT2013230003

Tomii RyoTraumatic Spinal Cord Injury

Start: 2023-03-01Target: 33Updated: 2025-07-18

Double-Blind, Randomized, Controlled Study of Multiple Intravenous Administration of Human Mesenchymal Stem Cells Derived from Bone Marrow in Patients with Amyotrophic Lateral Sclerosis.

RecruitingJPRN-jRCT2033240715

Tomii RyoAmyotrophic lateral sclerosis (ALS)

Start: 2025-04-14Target: 106Updated: 2025-09-15

Unknown Phase

Evaluation of efficacy and safety of autologous bone marrow mesenchymal stem cells for traumatic spinal cord injury: Use-results comparative survey

RecruitingJPRN-jRCT2053210130

Room Stemirac InformationSpinal Cord Injury

Start: 2019-05-16Target: 612Updated: 2025-10-13